Efficacy of Switching or Adding Pegylated Interferon in Chronic Hepatitis B Patients on Long Term Oral Antiviral Therapy

NCT01928511 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

254

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: peg-interferon alpha 2b, 1.5mcg/kg s/c given weekly
DRUG: Nucleos(t)ide analogue therapy

Sponsor

Seng Gee Lim

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]